Disclosure of Voting Rights in IDEX Biometrics to Chair, Morten Opstad – 9 April 2025

GlobeNewswire
04-10

At the close of business on 9 April 2025, Morten Opstad, chair of the board of IDEX Biometrics ASA, held the following voting rights in IDEX Biometrics, for the extraordinary general meeting on 11 April 2025.

Total 265,382,308 shares or 31.9% of the share capital and votes, including shares held by Mr. Opstad and close relations.

Some of the proxies may include voting instructions.

Contact persons
Marianne Bøe, Head of Investor Relations, Tel.: +47 918 00186
Kristian Flaten, CFO, Tel.: +47 950 92322
E-mail: ir@idexbiometrics.com


About IDEX Biometrics
IDEX Biometrics ASA (OSE: IDEX) is a global technology leader in fingerprint biometrics, offering authentication solutions across payments, access control, and digital identity.  Our solutions bring convenience, security, peace of mind and seamless user experiences to the world. Built on patented and proprietary sensor technologies, integrated circuit designs, and software, our biometric solutions target card-based applications for payments and digital authentication. As an industry-enabler we partner with leading card manufacturers and technology companies to bring our solutions to market.

For more information, visit www.idexbiometrics.com (http://www.idexbiometrics.com)

About this notice
This notice was issued by Erling Svela, VP finance, on 10 April 2024 at 02:45 CET on behalf of IDEX Biometrics ASA. The information shall be disclosed according to section 4‑2 of the Norwegian Securities Trading Act (STA) and published in accordance with section 5-12 the Norwegian Securities Trading Act.


免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10